IL21R and autoimmune disease: Knowledge of the biological functions of IL-21 has led to clinical trials using this cytokine alone or in combination with other agents in treating metastatic cancers, and blocking antibodies to IL-21R are now being evaluated in clinical trials for the treatment of autoimmune diseases.